QA: Harrow INC in us_pharma/2023

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001360214_2024_Harrow_INC.pdf

Logs

Graph

Absolute values for 0001360214, Harrow INC

  xvar xval
0 AssetsCurrent 139,482,000
1 IntangibleAssetsNetIncludingGoodwill 160,238,000
2 PropertyPlantAndEquipmentNet 3,521,000
3 remainder_Assets 8,923,000
4 LiabilitiesCurrent 49,344,000
5 LiabilitiesNoncurrent 6,524,000
6 remainder_Liabilities 185,885,000
7 CostOfGoodsAndServicesSold 47,499,879
8 SellingGeneralAndAdministrativeExpense 207,053,176
9 ResearchAndDevelopmentExpense 4,971,036
10 remainder_Expenses 1,008,204
11 remainder_Revenues 337,609,738
12 remainder_NetIncome -22,264,340
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 312,164,000
1 Liabilities 241,753,000
2 Expenses 260,532,295
3 Revenues 337,609,738
4 StockholdersEquity 70,411,000
5 NetIncome 54,813,103
6 ComprehensiveNetIncome 54,813,103
7 BaseVar 587,161,686
8 EconomicCapitalRatiobeforeLimitedLiability 0.752
9 EconomicCapitalRatio 2.10

Edgar->Model Mapping

Feature Distribution

Change over Time